カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のペースメーカー及び植込み型除細動器（ICD）市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO18201）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO18201
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：104
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のペースメーカー及び植込み型除細動器（ICD）市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ペースメーカー及び植込み型除細動器（ICD）市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のペースメーカー及び植込み型除細動器（ICD）の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ペースメーカー及び植込み型除細動器（ICD）市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ペースメーカー、植込み型除細動器

用途別セグメントは次のように区分されます。
・病院、専門クリニック・心臓センター、外来センター、その他

世界のペースメーカー及び植込み型除細動器（ICD）市場の主要な市場プレーヤーは以下のとおりです。
・Medtronic Inc.、Boston Scientific、ZOLL Medical Corp.、Asahi Kasei Corp.、Nihon Kohden Corp.、Shree Pacetronix Ltd.、St. Jude Medical, Inc、BIOTRONIK SE & Co. KG、EBR Systems, Inc.、MEDICO S.p.A.、Osypka Medical GmbH、Physio-Control Corp.

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ペースメーカー及び植込み型除細動器（ICD）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なペースメーカー及び植込み型除細動器（ICD）メーカーの企業概要、2019年～2022年までのペースメーカー及び植込み型除細動器（ICD）の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なペースメーカー及び植込み型除細動器（ICD）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ペースメーカー及び植込み型除細動器（ICD）の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのペースメーカー及び植込み型除細動器（ICD）の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのペースメーカー及び植込み型除細動器（ICD）市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびペースメーカー及び植込み型除細動器（ICD）の産業チェーンを掲載しています。
・第13、14、15章では、ペースメーカー及び植込み型除細動器（ICD）の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ペースメーカー及び植込み型除細動器（ICD）の概要
- 種類別分析（2017年vs2021年vs2028年）：ペースメーカー、植込み型除細動器
- 用途別分析（2017年vs2021年vs2028年）：病院、専門クリニック・心臓センター、外来センター、その他
- 世界のペースメーカー及び植込み型除細動器（ICD）市場規模・予測
- 世界のペースメーカー及び植込み型除細動器（ICD）生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Medtronic Inc.、Boston Scientific、ZOLL Medical Corp.、Asahi Kasei Corp.、Nihon Kohden Corp.、Shree Pacetronix Ltd.、St. Jude Medical, Inc、BIOTRONIK SE & Co. KG、EBR Systems, Inc.、MEDICO S.p.A.、Osypka Medical GmbH、Physio-Control Corp.
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ペースメーカー、植込み型除細動器
・用途別分析2017年-2028年：病院、専門クリニック・心臓センター、外来センター、その他
・ペースメーカー及び植込み型除細動器（ICD）の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ペースメーカー及び植込み型除細動器（ICD）のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ペースメーカー及び植込み型除細動器（ICD）のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ペースメーカー及び植込み型除細動器（ICD）の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ペースメーカー及び植込み型除細動器（ICD）の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Pacemakers and Implantable Cardioverter Defibrillators (ICDs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Pacemakers and Implantable Cardioverter Defibrillators (ICDs) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Pacemakers segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) include Medtronic Inc., Boston Scientific, ZOLL Medical Corp., Asahi Kasei Corp., and Nihon Kohden Corp., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pacemakers and Implantable Cardioverter Defibrillators (ICDs) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Pacemakers
Implantable Cardioverter Defibrillators
Market segment by Application can be divided into
Hospitals
Speciality Clinics & Cardiac Centres
Ambulatory centres
Others
The key market players for global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) market are listed below:
Medtronic Inc.
Boston Scientific
ZOLL Medical Corp.
Asahi Kasei Corp.
Nihon Kohden Corp.
Shree Pacetronix Ltd.
St. Jude Medical, Inc
BIOTRONIK SE & Co. KG
EBR Systems, Inc.
MEDICO S.p.A.
Osypka Medical GmbH
Physio-Control Corp.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pacemakers and Implantable Cardioverter Defibrillators (ICDs), with price, sales, revenue and global market share of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) from 2019 to 2022.
Chapter 3, the Pacemakers and Implantable Cardioverter Defibrillators (ICDs) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pacemakers and Implantable Cardioverter Defibrillators (ICDs) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pacemakers and Implantable Cardioverter Defibrillators (ICDs) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pacemakers and Implantable Cardioverter Defibrillators (ICDs).
Chapter 13, 14, and 15, to describe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Pacemakers
1.2.3 Implantable Cardioverter Defibrillators
1.3 Market Analysis by Application
1.3.1 Overview: Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Speciality Clinics & Cardiac Centres
1.3.4 Ambulatory centres
1.3.5 Others
1.4 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Size & Forecast
1.4.1 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales in Volume (2017-2028)
1.4.3 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Price (2017-2028)
1.5 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Production Capacity Analysis
1.5.1 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Total Production Capacity (2017-2028)
1.5.2 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Drivers
1.6.2 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Restraints
1.6.3 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Trends Analysis
2 Manufacturers Profiles
2.1 Medtronic Inc.
2.1.1 Medtronic Inc. Details
2.1.2 Medtronic Inc. Major Business
2.1.3 Medtronic Inc. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
2.1.4 Medtronic Inc. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Boston Scientific
2.2.1 Boston Scientific Details
2.2.2 Boston Scientific Major Business
2.2.3 Boston Scientific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
2.2.4 Boston Scientific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 ZOLL Medical Corp.
2.3.1 ZOLL Medical Corp. Details
2.3.2 ZOLL Medical Corp. Major Business
2.3.3 ZOLL Medical Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
2.3.4 ZOLL Medical Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Asahi Kasei Corp.
2.4.1 Asahi Kasei Corp. Details
2.4.2 Asahi Kasei Corp. Major Business
2.4.3 Asahi Kasei Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
2.4.4 Asahi Kasei Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Nihon Kohden Corp.
2.5.1 Nihon Kohden Corp. Details
2.5.2 Nihon Kohden Corp. Major Business
2.5.3 Nihon Kohden Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
2.5.4 Nihon Kohden Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Shree Pacetronix Ltd.
2.6.1 Shree Pacetronix Ltd. Details
2.6.2 Shree Pacetronix Ltd. Major Business
2.6.3 Shree Pacetronix Ltd. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
2.6.4 Shree Pacetronix Ltd. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 St. Jude Medical, Inc
2.7.1 St. Jude Medical, Inc Details
2.7.2 St. Jude Medical, Inc Major Business
2.7.3 St. Jude Medical, Inc Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
2.7.4 St. Jude Medical, Inc Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 BIOTRONIK SE & Co. KG
2.8.1 BIOTRONIK SE & Co. KG Details
2.8.2 BIOTRONIK SE & Co. KG Major Business
2.8.3 BIOTRONIK SE & Co. KG Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
2.8.4 BIOTRONIK SE & Co. KG Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 EBR Systems, Inc.
2.9.1 EBR Systems, Inc. Details
2.9.2 EBR Systems, Inc. Major Business
2.9.3 EBR Systems, Inc. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
2.9.4 EBR Systems, Inc. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 MEDICO S.p.A.
2.10.1 MEDICO S.p.A. Details
2.10.2 MEDICO S.p.A. Major Business
2.10.3 MEDICO S.p.A. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
2.10.4 MEDICO S.p.A. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Osypka Medical GmbH
2.11.1 Osypka Medical GmbH Details
2.11.2 Osypka Medical GmbH Major Business
2.11.3 Osypka Medical GmbH Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
2.11.4 Osypka Medical GmbH Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Physio-Control Corp.
2.12.1 Physio-Control Corp. Details
2.12.2 Physio-Control Corp. Major Business
2.12.3 Physio-Control Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
2.12.4 Physio-Control Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Breakdown Data by Manufacturer
3.1 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
3.4 Market Concentration Rate
3.4.1 Top 3 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Manufacturer Market Share in 2021
3.4.2 Top 6 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Manufacturer Market Share in 2021
3.5 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Size by Region
4.1.1 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales in Volume by Region (2017-2028)
4.1.2 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Region (2017-2028)
4.2 North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue (2017-2028)
4.3 Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue (2017-2028)
4.4 Asia-Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue (2017-2028)
4.5 South America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue (2017-2028)
4.6 Middle East and Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales in Volume by Type (2017-2028)
5.2 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Type (2017-2028)
5.3 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales in Volume by Application (2017-2028)
6.2 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Application (2017-2028)
6.3 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Type (2017-2028)
7.2 North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Application (2017-2028)
7.3 North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Size by Country
7.3.1 North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales in Volume by Country (2017-2028)
7.3.2 North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Type (2017-2028)
8.2 Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Application (2017-2028)
8.3 Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Size by Country
8.3.1 Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales in Volume by Country (2017-2028)
8.3.2 Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Type (2017-2028)
9.2 Asia-Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Application (2017-2028)
9.3 Asia-Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Size by Region
9.3.1 Asia-Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Type (2017-2028)
10.2 South America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Application (2017-2028)
10.3 South America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Size by Country
10.3.1 South America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales in Volume by Country (2017-2028)
10.3.2 South America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Type (2017-2028)
11.2 Middle East & Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Application (2017-2028)
11.3 Middle East & Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Size by Country
11.3.1 Middle East & Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
12.3 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Production Process
12.4 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Typical Distributors
13.3 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Medtronic Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Medtronic Inc. Major Business
Table 5. Medtronic Inc. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
Table 6. Medtronic Inc. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 8. Boston Scientific Major Business
Table 9. Boston Scientific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
Table 10. Boston Scientific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. ZOLL Medical Corp. Basic Information, Manufacturing Base and Competitors
Table 12. ZOLL Medical Corp. Major Business
Table 13. ZOLL Medical Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
Table 14. ZOLL Medical Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Asahi Kasei Corp. Basic Information, Manufacturing Base and Competitors
Table 16. Asahi Kasei Corp. Major Business
Table 17. Asahi Kasei Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
Table 18. Asahi Kasei Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Nihon Kohden Corp. Basic Information, Manufacturing Base and Competitors
Table 20. Nihon Kohden Corp. Major Business
Table 21. Nihon Kohden Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
Table 22. Nihon Kohden Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Shree Pacetronix Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Shree Pacetronix Ltd. Major Business
Table 25. Shree Pacetronix Ltd. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
Table 26. Shree Pacetronix Ltd. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. St. Jude Medical, Inc Basic Information, Manufacturing Base and Competitors
Table 28. St. Jude Medical, Inc Major Business
Table 29. St. Jude Medical, Inc Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
Table 30. St. Jude Medical, Inc Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. BIOTRONIK SE & Co. KG Basic Information, Manufacturing Base and Competitors
Table 32. BIOTRONIK SE & Co. KG Major Business
Table 33. BIOTRONIK SE & Co. KG Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
Table 34. BIOTRONIK SE & Co. KG Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. EBR Systems, Inc. Basic Information, Manufacturing Base and Competitors
Table 36. EBR Systems, Inc. Major Business
Table 37. EBR Systems, Inc. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
Table 38. EBR Systems, Inc. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. MEDICO S.p.A. Basic Information, Manufacturing Base and Competitors
Table 40. MEDICO S.p.A. Major Business
Table 41. MEDICO S.p.A. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
Table 42. MEDICO S.p.A. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Osypka Medical GmbH Basic Information, Manufacturing Base and Competitors
Table 44. Osypka Medical GmbH Major Business
Table 45. Osypka Medical GmbH Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
Table 46. Osypka Medical GmbH Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Physio-Control Corp. Basic Information, Manufacturing Base and Competitors
Table 48. Physio-Control Corp. Major Business
Table 49. Physio-Control Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product and Services
Table 50. Physio-Control Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 52. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Pacemakers and Implantable Cardioverter Defibrillators (ICDs), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Production Site of Key Manufacturer
Table 56. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) New Entrant and Capacity Expansion Plans
Table 57. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Mergers & Acquisitions in the Past Five Years
Table 58. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Region (2017-2022) & (K Units)
Table 59. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Region (2023-2028) & (K Units)
Table 60. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Type (2017-2022) & (K Units)
Table 63. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Type (2023-2028) & (K Units)
Table 64. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Price by Type (2017-2022) & (US$/Unit)
Table 67. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Price by Type (2023-2028) & (US$/Unit)
Table 68. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Application (2017-2022) & (K Units)
Table 69. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Application (2023-2028) & (K Units)
Table 70. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Price by Application (2017-2022) & (US$/Unit)
Table 73. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Price by Application (2023-2028) & (US$/Unit)
Table 74. North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Country (2017-2022) & (K Units)
Table 75. North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Country (2023-2028) & (K Units)
Table 76. North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Type (2017-2022) & (K Units)
Table 79. North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Type (2023-2028) & (K Units)
Table 80. North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Application (2017-2022) & (K Units)
Table 81. North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Application (2023-2028) & (K Units)
Table 82. Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Country (2017-2022) & (K Units)
Table 83. Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Country (2023-2028) & (K Units)
Table 84. Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Type (2017-2022) & (K Units)
Table 87. Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Type (2023-2028) & (K Units)
Table 88. Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Application (2017-2022) & (K Units)
Table 89. Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Application (2023-2028) & (K Units)
Table 90. Asia-Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Region (2017-2022) & (K Units)
Table 91. Asia-Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Region (2023-2028) & (K Units)
Table 92. Asia-Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Type (2017-2022) & (K Units)
Table 95. Asia-Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Type (2023-2028) & (K Units)
Table 96. Asia-Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Application (2017-2022) & (K Units)
Table 97. Asia-Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Application (2023-2028) & (K Units)
Table 98. South America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Country (2017-2022) & (K Units)
Table 99. South America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Country (2023-2028) & (K Units)
Table 100. South America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Type (2017-2022) & (K Units)
Table 103. South America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Type (2023-2028) & (K Units)
Table 104. South America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Application (2017-2022) & (K Units)
Table 105. South America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Application (2023-2028) & (K Units)
Table 106. Middle East & Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Region (2017-2022) & (K Units)
Table 107. Middle East & Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Region (2023-2028) & (K Units)
Table 108. Middle East & Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Type (2017-2022) & (K Units)
Table 111. Middle East & Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Type (2023-2028) & (K Units)
Table 112. Middle East & Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Application (2017-2022) & (K Units)
Table 113. Middle East & Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Application (2023-2028) & (K Units)
Table 114. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Raw Material
Table 115. Key Manufacturers of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Typical Distributors
Table 119. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Typical Customers
List of Figures
Figure 1. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Picture
Figure 2. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Type in 2021
Figure 3. Pacemakers
Figure 4. Implantable Cardioverter Defibrillators
Figure 5. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Application in 2021
Figure 6. Hospitals
Figure 7. Speciality Clinics & Cardiac Centres
Figure 8. Ambulatory centres
Figure 9. Others
Figure 10. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (2017-2028) & (K Units)
Figure 13. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Price (2017-2028) & (US$/Unit)
Figure 14. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Production Capacity (2017-2028) & (K Units)
Figure 15. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Drivers
Figure 17. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Restraints
Figure 18. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Trends
Figure 19. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Manufacturer in 2021
Figure 20. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Manufacturer in 2021
Figure 21. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Region (2017-2028)
Figure 25. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Region (2017-2028)
Figure 26. North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue (2017-2028) & (USD Million)
Figure 27. Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue (2017-2028) & (USD Million)
Figure 29. South America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue (2017-2028) & (USD Million)
Figure 31. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Type (2017-2028)
Figure 32. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Type (2017-2028)
Figure 33. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Application (2017-2028)
Figure 35. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Application (2017-2028)
Figure 36. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Type (2017-2028)
Figure 38. North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Application (2017-2028)
Figure 39. North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Country (2017-2028)
Figure 40. North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Country (2017-2028)
Figure 41. United States Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Type (2017-2028)
Figure 45. Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Application (2017-2028)
Figure 46. Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Country (2017-2028)
Figure 47. Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Country (2017-2028)
Figure 48. Germany Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Region (2017-2028)
Figure 57. China Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Type (2017-2028)
Figure 64. South America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Application (2017-2028)
Figure 65. South America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Country (2017-2028)
Figure 66. South America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) in 2021
Figure 78. Manufacturing Process Analysis of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
Figure 79. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のペースメーカー及び植込み型除細動器市場2022年：市場規模予測（～2028年）
  • 植込み型除細動器 (ICD) 装置のグローバル市場展望 2023年-2029年：単腔ICD、二腔ICD
  • 血管外植込み型除細動器システムのグローバル市場展望 2023年-2029年：同期型、非同期型
  • 世界の植込み型除細動器（ICD）デバイス市場2022年：市場規模予測（～2028年）
  • 世界の医療用ポリイソプレン（PI）市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO18201 )"世界のペースメーカー及び植込み型除細動器（ICD）市場2022年：市場規模予測（～2028年）" (英文：Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。